(CIX: WRAL30)  1,027.03  up arrow+10.73  (1.06 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Apple)  95.78  up arrow+0.79  (0.83 %)  Updated: 09:42 AM EST, Feb 10 2016
(NY: QUINTILES)  58.09  up arrow+1.39  (2.45 %)  Updated: 09:42 AM EST, Feb 10 2016
(OP: BASF SE)  64.89  down arrow-0.15  (-0.23 %)  Updated: 09:39 AM EST, Feb 10 2016
(NQ: BioCryst)  1.89    (0 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: BioDelivery)  3.54  down arrow-0.03  (-0.84 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: CEMP)  16.72  up arrow+0.23  (1.39 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Cisco)  23.00  up arrow+0.35  (1.55 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Cree)  29.44  up arrow+0.08  (0.27 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EST, Dec 04 2015
(NY: EMC)  24.33  up arrow+0.16  (0.66 %)  Updated: 09:42 AM EST, Feb 10 2016
(NQ: Extreme Networks)  2.55  up arrow+0.03  (1.19 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Facebook)  100.94  up arrow+1.4  (1.41 %)  Updated: 09:42 AM EST, Feb 10 2016
(NY: GLAXOSMITHKLINE)  39.47  up arrow+0.13  (0.33 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Alphabet)  690.00  up arrow+11.89  (1.75 %)  Updated: 09:41 AM EST, Feb 10 2016
(NY: IBM)  124.58  up arrow+0.51  (0.41 %)  Updated: 09:41 AM EST, Feb 10 2016
(NY: LH)  104.26  up arrow+1.73  (1.68 %)  Updated: 09:41 AM EST, Feb 10 2016
(OP: Lenovo Group)  16.62  up arrow+0.12  (0.73 %)  Updated: 09:38 AM EST, Feb 10 2016
(NY: MRK)  49.91  up arrow+0.75  (1.53 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Microsoft)  50.02  up arrow+0.74  (1.5 %)  Updated: 09:42 AM EST, Feb 10 2016
(NQ: NetApp)  22.14  up arrow+0.1  (0.45 %)  Updated: 09:42 AM EST, Feb 10 2016
(NY: NOVARTIS AG)  73.48  up arrow+0.86  (1.18 %)  Updated: 09:41 AM EST, Feb 10 2016
(OP: Novozymes A/S)  41.26  up arrow+0.26  (0.63 %)  Updated: 09:30 AM EST, Feb 10 2016
(NY: Pfizer)  29.49  up arrow+0.39  (1.32 %)  Updated: 09:42 AM EST, Feb 10 2016
(NQ: Pozen)  5.94    (0 %)  Updated: 08:10 PM EST, Feb 05 2016
(NY: Red Hat)  63.62  up arrow+2.02  (3.28 %)  Updated: 09:42 AM EST, Feb 10 2016
(NQ: BBRY)  6.74  up arrow+0.02  (0.3 %)  Updated: 09:41 AM EST, Feb 10 2016
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  12.46  up arrow+0.41  (3.4 %)  Updated: 09:30 AM EST, Feb 10 2016
Updated 7:57 a.m. today

Thought leaders gather in Raleigh to create Internet of Things roadmap

Internet  A National Science Foundation-supported conference at NCSU over the next two days will explore the creation of a roadmap toward developing a national Internet of Things strategy. Here's a preview of what's going on.

7:08 a.m. today

Premium Lock What are top 3 disruptors in FinTech? Report makes the case

A new research report from Juniper breaks down what its analysts view as the top disruptors in the financial technical services, or FinTech, space. Our WTW Insider subscribers get a look at the top three.

Trying out Apple Pay Trying out Apple Pay

Latest for Insiders

6:46 a.m. today

HQ Raleigh promising big news - Could it be Charlotte, Charleston expansion?

HQ Raleigh Does HQ Raleigh's Big News Involve Charlotte's Packard Place? A Charleston Campus? Similar messaging on social media by startup hubs in Raleigh and Charlotte hint at big news for the state's startup ecosystem this week.

6:36 a.m. today

'DJ Watson:' IBM's Watson joins Moogfest lineup

Moogest 2016 Watson will help Moogfest attendees compose their own songs, but there will be plenty of human performers, too, at the Durham event. New additions include synth-pop band Grimes and pop trio Mike Snow.

Tags: IBM, Internet
6:20 a.m. today

Report: SEC investigating former Salix executives

Salix        The former CEO and CFO of Salix Pharmaceuticals, which was sold to Valeant Pharmaceuticals for more than $11 billion a year ago, are being investigated by the SEC, according to the Reuters news service.

1:11 p.m. yesterday

Premium Lock Novozymes reorganizes; changes may create some new jobs

Novozymes Novozymes, a global company focusing on enzyme development and production, is reorganizing. Its North America leader explains what's happening and says there will be some new jobs as a result.

12:54 p.m. yesterday

NC IDEA launching next round of startup grant applications

NC IDEA NC IDEA will launch its next round of awarding up to $50,000 in non-dilutive grants to startups on Feb. 15. Entrepreneurs can learn more about the program at a series of state-wide meetings. and webinars.

Updated 8:22 a.m. yesterday

Jobless future? NC Science and Math robotics team remains gung ho

Amid the doom and gloom about a possible jobless future due to technology automation and robotics, a team of North Carolina School of Science and Mathematics - The Zebracorns - remain excited about the future.

12:07 p.m. yesterday

Premium Lock Durham-based Chimerix reports progress in smallpox vaccine

Bioterror     Chimerix, which has a contract potentially worth more than $400 million in the development of a first vaccine targeting smallpox, reports progress in development of an antiviral. In recent tests, its brincidofovir successfully treated 100 percent of animals infected with rabbitpox.

11:42 a.m. yesterday

Premium Lock Cognizant's growth throwing a 'cloud' over rivals IBM, Accenture

Analysis: Cognizant is increasingly encroaching on IBM and Accenture's territory by building out its consulting scale and digital and cloud expertise, writes Technology Business research Analyst Jennifer Hamel. Our Insiders get the full story.

Cloud computing Cloud computing

Updated 7:32 a.m. yesterday

Premium Lock Stampede! A 71% share wipeout for Biocryst after drug trial failure

Talk about a sell-off. Early Monday, Triangle-based Biocryst disclosed news that a drug candidate targeting a rare genetic condition had failed. The news set off an immediate plunge in its share price, triggered a Wall Street downgrade - and a possible lawsuit.

Biocryst plunges Biocryst plunges

6:50 a.m. yesterday

Premium Lock Bob Ingram is new chair at Novan; Neal Hunter steps down

Novan Therapeutics Novan Therapeutics, a high-profile emerging pharmaceutical firm backed by big-name investors in the Triangle with a focus on developing new dermatology treatments, has a new chairman. But his name is a familiar one. Another well-known name leaves the board in the shuffle.

2:35 p.m. Monday

Premium Lock Inside Lenovo: Finding ways to overcome PC market woes is a priority

Lenovo's gaming-geared laptop  Analysis: Lenovo's latest earnings report highlights the challenges the world's No. 1 PC maker faces as inorganic growth disappears. So says Technology Business Research analyst Jack Narcotta.

Updated 6:48 a.m. Monday

Premium Lock How can workers avoid becoming obsolete? A Q&A with Dr. Mike Walden

Is there a "Moore's Law" for technology-related job losses? Just as decades ago what came to be known as Moore's law forecast ever-increases in computer chip processing power, a new "law" has emerged: The faster technology develops, the more traditional jobs are lost. In a Q&A, NCSU Economist Mike Walden talks about the "jobless future" and how workers can avoid becoming obsolete.

Mike Walden Mike Walden

Updated 6:43 a.m. Monday

Raleigh forum's focus: How can NC deal with threat of jobless future?

Is a jobless future coming for North Carolina? As robotics, artificial intelligence and technology continue to evolve at a rapid rate, North Carolina faces a staggering 50 percent loss of jobs in the coming decades, according to an NCSU study. How can the state prevent such a debacle is the topic of a major forum in Raleigh.

Future Work Future Work

Updated 2:46 p.m. Monday

Premium Lock Workforce expert: Healthcare jobs will change but the field remains 'hands on'

Healthcare workers are hardly immune from the threat of a jobless future as being explored in this week's Emerging Issues Forum "Future Work" conference. But as one of speakers explains opportunities will remain available for humans in healthcare.

Reg Javier Reg Javier

Updated 2:25 p.m. Monday

CED picks 50-plus emerging startups to present at Life Science Conference

CED Life Science Conference 2016 More than 50 emerging life science startups will have the chance to make their case for investment to possible backers at the CED's Life Science Conference next month. The CED announced its selections early Monday.

Updated 2:24 p.m. Monday

Host of investors, entrepreneurs headline 10th Southeast Venture Conference

SEVC The 10th annual Southeast Venture Conference, which is the largest such event put on in the region, is set for March 16-17 in Tysons Corner, Va. Highlighting the program is a host of speakers ranging from startups and entrepreneurs to venture capitalists. Among the headliners: The founder of 500 Startups.

Updated 6:25 a.m. yesterday

Pozen name disappears after merger is closed

Pozen The name Pozen has disappeared following the closing of the merger between the Chapel Hill-based pharmaceutical firm and Canada-based Tribute.

6:33 a.m. yesterday

First person: 'How I pitched and won at Triangle Startup Weekend'

Exit Event From idea to market validation in 48 hours: A "Startup Weekend - Social Impact" story as written by Jason Parker for ExitEvent.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith